舒泰神股价微涨0.95% 公司推进BDB-001临床试验

Group 1 - The stock price of Shutaishen reached 49.90 yuan as of August 8, 2025, with an increase of 0.95% compared to the previous trading day and a trading volume of 704 million yuan, showing a fluctuation of 6.11% [1] - Shutaishen operates in the biopharmaceutical industry, focusing on the research and development of innovative drugs, particularly monoclonal antibodies [1] - The company has indicated on its interactive platform that it will continue to advance the clinical trial progress of BDB-001, a large molecule antibody inhibitor targeting the C5a factor, which has a different mechanism of action compared to similar drugs [1] Group 2 - On August 8, Shutaishen experienced a net outflow of 240,200 yuan in principal funds, with a cumulative net outflow of 268 million yuan over the past five days [2]